These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 8876215)

  • 21. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.
    Noss EH; Harding CV; Boom WH
    Cell Immunol; 2000 Apr; 201(1):63-74. PubMed ID: 10805975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence.
    Szalay G; Hess J; Kaufmann SH
    Eur J Immunol; 1994 Jul; 24(7):1471-7. PubMed ID: 8026511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis.
    Chun T; Serbina NV; Nolt D; Wang B; Chiu NM; Flynn JL; Wang CR
    J Exp Med; 2001 May; 193(10):1213-20. PubMed ID: 11369792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Listeriolysin generates a route for the presentation of exogenous antigens by major histocompatibility complex class I.
    Darji A; Chakraborty T; Wehland J; Weiss S
    Eur J Immunol; 1995 Oct; 25(10):2967-71. PubMed ID: 7589099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Lipoprotein Rv1016c Derived from
    Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
    Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs.
    Bouwer HG; Seaman MS; Forman J; Hinrichs DJ
    J Immunol; 1997 Sep; 159(6):2795-801. PubMed ID: 9300701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes.
    Potter NS; Harding CV
    J Immunol; 2001 Sep; 167(5):2538-46. PubMed ID: 11509593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.
    Burgdorf S; Schölz C; Kautz A; Tampé R; Kurts C
    Nat Immunol; 2008 May; 9(5):558-66. PubMed ID: 18376402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.
    Reis e Sousa C; Germain RN
    J Exp Med; 1995 Sep; 182(3):841-51. PubMed ID: 7650490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
    Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
    J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen presenting cells.
    Hamilos DL
    Immunol Res; 1989; 8(2):98-117. PubMed ID: 2659691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis.
    Mir SA; Sharma S
    Vaccine; 2013 Aug; 31(37):3818-25. PubMed ID: 23628242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.